Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Metastatic Breast Cancer × ribociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Multiple Endocrine Neoplasia Type 1 2 Unilateral Breast Neoplasms 1 Recurrence 1 Osteitis Deformans 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Breast Neoplasms, Male 1 Breast Diseases 1 Advanced Metastatic Breast Cancer 1

Interventions

ribociclib 1 Tamoxifen 1 Letrozole 1 Goserelin 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02278120 2024-03-12

MONALEESA-7

Novartis

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡